MARKET

RZONF

RZONF

Rize Oncology
EXMKT
0.160
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
0.160
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.160
52 WEEK LOW
0.160
MARKET CAP
12.12M
P/E (TTM)
-11.2676
1D
5D
1M
3M
1Y
5Y
1D
Rize Oncology Announces Completion of Private Placement and Resignation of Director
Newsfile · 11/04 21:27
Weekly Report: what happened at RZONF last week (0908-0912)?
Weekly Report · 09/15 12:41
Weekly Report: what happened at RZONF last week (0901-0905)?
Weekly Report · 09/08 12:42
Weekly Report: what happened at RZONF last week (0825-0829)?
Weekly Report · 09/01 12:34
Weekly Report: what happened at RZONF last week (0818-0822)?
Weekly Report · 08/25 12:53
About RZONF
Rize Oncology Inc., formerly GeneTether Therapeutics Inc., is a pharmaceutical company engaged in developing oncology therapies. The Company is focused on advancing treatments for soft tissue sarcoma. It is developing STS-201 for the treatment of soft tissue sarcoma. STS-201 is a small-molecule drug candidate that has exhibited significant utility in soft tissue sarcoma, as well as other types of cancers and certain proliferative diseases.

Webull offers Rize Oncology Inc stock information, including EXMKT: RZONF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RZONF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RZONF stock methods without spending real money on the virtual paper trading platform.